Apheresis Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2020 to 2025

Published on : Nov-2019 | List of Tables : 42 | List of Figures : 106 | No. of Pages : 170 | Report Code : FACT4352MR | Format : ppt pdf Excel Word

Favourable Reimbursement Scenario in Developed Regions Supporting Steady Growth of Apheresis Market

The introduction of new therapy lines such as stem cell therapy, immunoglobulin therapy, and radiotherapy for control and prevention of chronic diseases is inadvertently bolstering the adoption of apheresis procedures, in turn boosting the growth of the global apheresis market. Governments of North America and Europe are diverting investments towards encouraging the adoption of quality healthcare through various programs such as Medicare, Medicaid, employee insurance programs, and Veterans Health Administration, which alleviates high-cost concerns regarding apheresis procedures.

Lack of regular blood donors is being countered by private blood collection centres that attract donors through paid plans. In recent times, hospitals are increasing the adoption of apheresis equipment to collect and store required blood components, so as to reduce dependency on private suppliers and blood collection centres. Given the influence of these dynamics, research by Fact.MR projects the apheresis market to grow 2X during the forecast period (2020 - 2025).

key segments in apheresis market

For detailed insights on market taxonomy, request a sample copy of the report here.

Shift from Single Dose to Double Dose Apheresis to Create Opportunities for Disposable Products

The healthcare sector is constantly plagued by a disproportionately high unmet need for blood components. As a result, a shift away from single dose towards double dose apheresis is observed to increase the yield of blood components. The shift is also creating an indispensable need to separate multiple components at once, which is driving the development of advanced products such as plasma separators and immunoadsorbent. The trend of adopting double dose apheresis procedures is specifically dominant in Japan, Germany, and the U.S. markets.

Disposables will remain preferred products in the apheresis market over devices, as advancements in apheresis equipment differentiate the types of columns, blood lines, and tubing. In addition, the frequency of use of these products is comparatively higher than the adoption of devices, which is projected to retain lucrative prospects from the sales of disposable products.  

New Revenue Streams for Apheresis Procedures from Expansion of Application Scope

According to guidelines for apheresis procedures as provided by the American Society for Apheresis (ASFA), there are over 87 diseases that can be treated using the apheresis procedure as the sole line or as supportive treatment. Manufacturers of apheresis equipment are capitalizing on this opportunity to foster innovation in these products, and validate them based on evidence to target novel applications.

Among other applications, evidence-based use of apheresis procedures for neurological applications is projected to create a significant revenue stream for the apheresis market. Moreover, increasing use of radiotherapy or chemotherapy and incidence of damaged bone marrow are likely to unlock profitable avenues from apheresis procedures used for the treatment of cancer.

Understanding Impact of Underlying Challenges Present in Apheresis Market

Despite the emergence of new revenue channels for the apheresis market, there are numerous challenges present in the landscape, which could inadvertently narrow growth prospects. A key barrier to growth is the lack of skilled professionals. Recent times have witnessed an epochal scale of technological changes, which has revolutionized the healthcare industry, and, in turn, its operations. However, scarcity of expert operators leads to an increase in acquisition cost of well-informed resources, which adds up to the already high cost of apheresis procedures.

Healthcare expenses in developed regions such as North America and Europe are offset through government initiatives and reimbursement programs. However, cost concerns in developing and underdeveloped regions could shrink opportunities for players in the apheresis market, though these present highly lucrative, yet largely untapped markets.

opportunity analysis in key countries in apheresis market

For detailed regional analysis, request a sample copy of the report here.

Cost-competitiveness - A Key Strategy to Grow in Developing Regions

High technological prowess coupled with government aid supporting research & development activities is increasing the concentration of manufacturers in North America. Advancements in the healthcare sector and progressive improvements in the quality of services have been increasing patients’ reliance on hospitals and clinics. Besides this, easy access to advanced apheresis products, on the backdrop of ongoing development initiatives undertaken by market players, further expands the patient pool in the region. Considering these drivers, North America is expected to lead the growth of the apheresis market, with the regional market registering a CAGR of ~10% during the forecast period.

Among other regions, manufacturers in the apheresis market in Japan are taking the technological approach to foster innovation in the development of apheresis products, which is anticipated to strengthen the Asia Pacific apheresis market. Though reimbursement scenarios are likely to offer coverage in developing countries in future, it is imperative that market players adopt a cost-competitive strategy to achieve better penetration rate of products in these regions.

Request research methodology of this report.

Apheresis Market - Scope of the Study

Fact.MR, in its recently published research report on the apheresis market, offers actionable intelligence and key winning strategies for stakeholders in the global apheresis market. This exclusive study provides rare and relevant insights into weighted dynamics, which directly or indirectly influence the growth of the apheresis market during the forecast period (2020 - 2025).

With the help of key insights offered by this exclusive study, stakeholders will gain a brief idea regarding the growth of the apheresis market, and will be able to make informed business decisions. This detailed market study provides qualitative as well as quantitative data about the drivers, threats, restraints, and opportunities present in the apheresis market. The report also measures the impact of each of these dynamics to estimate the size of the apheresis market for the given period.

Authors of the report have taken ample care to measure and include the relevance and impact of microeconomic as well as macroeconomic factors that holds potential to influence growth of the apheresis market during the forecast period. The global study on the apheresis market includes Porter’s Five Forces analysis, in order to present the buyer’s and supplier’s power in the landscape. In addition, the analysis also discusses the threat of substitutes and new entrants, which provides a brief idea regarding the future growth course of the apheresis market.

The global study offers crucial information about global, regional, and local players operating in the apheresis market, along with their estimated market share. Market share has been estimated in terms of value (US$ Mn). Besides providing key information regarding the concentration of leading, prominent, and local players in the apheresis market, the study also aims at equipping stakeholders with the best of information regarding their winning strategies, recent developments, and financials.

Apheresis Market - Assessment of Key Segments

With an aim to offer granular level insights into the apheresis market, authors of the report have segmented the landscape on the basis of end user, technology, procedure, application, product, and region. This global research report also analyses the incremental opportunity available in the apheresis market during the forecast period. Key segments of the apheresis market include:

End User

Technology

Procedure

Application

Product

Region

Hospitals

Centrifugation

Plasmapheresis

Renal Diseases

Devices

North America

Blood Collection Centres

  • Public
  • Private

Membrane Filtration

Photopheresis

Neurology

Disposables

Europe

 

 

LDL Apheresis

Haematology

 

Asia Pacific

 

 

Plateletpheresis

Cancer

 

Latin America

 

 

Leukapheresis

Autoimmune Diseases

 

Middle East &Africa

 

 

Erythrocytapheresis

Cardiovascular Diseases

 

 

 

 

Others (Lymphapheresis and extracorporeal immunoadsorption)

Others (Fibrosis and Diabetes)

 

 

This detailed guide, based on the latest market movement, ensures that only precise information reaches stakeholders, so as to help them gain an upper hand over their competitors in the apheresis market. This exclusive guide offers crucial information about the current trends, pipeline drugs, unmet drugs, future scope, and government regulations for the apheresis market.

Key players profiled in this exclusive study on the apheresis market include Hemacare Corporation, Asahi Kasei Medical Co., Ltd, Therakos, Inc., B. Braun Melsungen AG, Terumo Corporation, Fresenius Medical Care, NIKKISO CO., LTD., Haemonetics Corp., Medica S.p.A., and Kawasumi Laboratories Inc.

Apheresis Market – Research Methodology

Research undertaken by seasoned analysts at Fact.MR consists of a systematic approach, including both, primary and secondary research methodologies. For conducting primary research, interviews and discussions were carried out with industry experts, key opinion leaders, vendors, and distributors. Besides these, respondents also include CEOs, presidents, directors, chairmen, vice presidents, marketing managers, suppliers, distributors, and chief medical officers, among others.

This helps in assessing the demand-supply gap prevailing in the apheresis market. In order to conduct secondary research, marketing collaterals, company websites, industry associations, and government statistics were studied. In addition to this, reports as well as content pieces published by credible sources, such as World Health Organization (WHO), PubMed (NCBI) articles, global and regional apheresis associations such as American Society for Apheresis (ASFA), American Association of Blood Banks (AABB), World Apheresis Association (WAA), U.S. Food and Drug Administration (FDA), Medical Dealer, Investing Daily, blogs, and others, were studied. Insights obtained through primary and secondary research are then authenticated with the data triangulation method.

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary

4. Market Definition

    4.1. Introduction

        4.1.1. Product/Service Definition

        4.1.2. Industry Evolution / Developments

    4.2. Market Overview

    4.3. Key Market Indicators

        4.3.1. Global Health Care Expenditure Scenario

    4.4. Market Dynamics

        4.4.1. Drivers

        4.4.2. Restraints

        4.4.3. Opportunities

    4.5. Apheresis Market (Therapeutic Apheresis & Donor Apheresis) Analysis and Forecast, 2016 – 2024

        4.5.1. Market Revenue Projections (US$ Mn)

    4.6. Apheresis Market (Therapeutic Apheresis & Donor Apheresis)  - Global Supply Demand Scenario

    4.7. Porter’s Five Force Analysis

    4.8. Event Impact Analysis

    4.9. Market Outlook

5. Global Apheresis Market (Therapeutic Apheresis & Donor Apheresis) Analysis and Forecasts, By Product

    5.1. Introduction & Definition

    5.2. Key Findings / Developments

    5.3. Key Trends

    5.4. Market Size (US$ Mn) Forecast By Product

        5.4.1. Devices

        5.4.2. Disposables

    5.5. Market Attractiveness By Product

6. Global Apheresis Market (Therapeutic Apheresis & Donor Apheresis) Analysis and Forecast, By Application

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Key Trends

    6.4. Market Size (US$ Mn) Forecast, By Application

        6.4.1. Renal diseases

        6.4.2. Neurology

        6.4.3. Hematology

        6.4.4. Cancer

        6.4.5. Autoimmune disease 

        6.4.6. Cardiovascular diseases 

        6.4.7. Others (e.g. Fibrosis, Diabetes, Dermatology etc.)

    6.5. Comparison Matrix

    6.6. Market Attractiveness By Application

7. Global Apheresis Market (Therapeutic Apheresis & Donor Apheresis) Analysis and Forecasts, By Procedure

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Key Trends

    7.4. Market Size (US$ Mn) Forecast By Procedure

        7.4.1. Plasmapheresis

        7.4.2. Photopheresis

        7.4.3. LDL-apheresis

        7.4.4. Plateletpheresis

        7.4.5. Leukapheresis

        7.4.6. Erythrocytapheresis

        7.4.7. Others (e.g. lymphapheresis, extracorporeal immunoadsorption, etc.)

    7.5. Comparison Matrix

    7.6. Market Attractiveness By Procedure 

8. Global Apheresis Market (Therapeutic Apheresis & Donor Apheresis) Analysis and Forecasts, By Technology

    8.1. Introduction & Definition

    8.2. Key Findings / Developments

    8.3. Key Trends

    8.4. Market Size (US$ Mn) Forecast By Technology

        8.4.1. Centrifugation

        8.4.2. Membrane filtration

    8.5. Comparison Matrix

    8.6. Market Attractiveness By Technology

9. Global Apheresis Market (Therapeutic Apheresis & Donor Apheresis) Analysis and Forecasts, By End User

    9.1. Introduction & Definition

    9.2. Key Findings / Developments

    9.3. Key Trends

    9.4. Market Size (US$ Mn) Forecast By End User

        9.4.1. Hospitals 

        9.4.2. Blood Collection Centers

            9.4.2.1. Public

            9.4.2.2. private

    9.5. Comparison Matrix

    9.6. Market Attractiveness By End User

10. Global Apheresis Market (Therapeutic Apheresis & Donor Apheresis) Analysis and Forecasts, By Region

    10.1. Key Findings

    10.2. Policies and Regulations

    10.3. Market Size (US$ Mn) Forecast By Region

        10.3.1. North America

        10.3.2. Europe

        10.3.3. Asia Pacific

        10.3.4. Latin America

        10.3.5. Middle East & Africa

    10.4. Market Attractiveness By Country/Region

11. North America Apheresis Market (Therapeutic Apheresis & Donor Apheresis) Analysis and Forecast

    11.1. Introduction & Definition

    11.2. Key Findings / Developments

    11.3. Key Trends

    11.4. Market Size (US$ Mn) Forecast, By Country

        11.4.1. U.S.

        11.4.2. Canada

    11.5. Market Size (US$ Mn) Forecast By Product

        11.5.1. Devices

        11.5.2. Disposables

    11.6. Market Size (US$ Mn) Forecast, By Application

        11.6.1. Renal diseases

        11.6.2. Neurology

        11.6.3. Hematology

        11.6.4. Cancer

        11.6.5. Autoimmune disease 

        11.6.6. Cardiovascular diseases 

        11.6.7. Others 

    11.7. Market Size (US$ Mn) Forecast By Procedure

        11.7.1. Plasmapheresis

        11.7.2. Photopheresis

        11.7.3. LDL-apheresis

        11.7.4. Plateletpheresis

        11.7.5. Leukapheresis

        11.7.6. Erythrocytapheresis

        11.7.7. Others 

    11.8. Market Size (US$ Mn) Forecast, By Technology

        11.8.1. Centrifugation

        11.8.2. Membrane filtration

    11.9. Market Size (US$ Mn) Forecast, By End User

        11.9.1. Hospitals 

        11.9.2. Blood Collection Centers

            11.9.2.1. Public

            11.9.2.2. private

    11.10. Market Attractiveness Analysis 

        11.10.1. By Country

        11.10.2. By Product

        11.10.3. By Application

        11.10.4. By Procedure

        11.10.5. By Technology

        11.10.6. By End User

12. Europe Apheresis Market (Therapeutic Apheresis & Donor Apheresis) Analysis and Forecast

    12.1. Introduction & Definition

    12.2. Key Findings / Developments

    12.3. Key Trends

    12.4. Market Size (US$ Mn) Forecast, By Country

        12.4.1. Germany

        12.4.2. France

        12.4.3. U.K.

        12.4.4. Italy 

        12.4.5. Spain

        12.4.6. Rest of Europe

    12.5. Market Size (US$ Mn) Forecast By Product

        12.5.1. Devices

        12.5.2. Disposables

    12.6. Market Size (US$ Mn) Forecast, By Application

        12.6.1. Renal diseases

        12.6.2. Neurology

        12.6.3. Hematology

        12.6.4. Cancer

        12.6.5. Autoimmune disease 

        12.6.6. Cardiovascular diseases 

        12.6.7. Others 

    12.7. Market Size (US$ Mn) Forecast By Procedure

        12.7.1. Plasmapheresis

        12.7.2. Photopheresis

        12.7.3. LDL apheresis

        12.7.4. Plateletpheresis

        12.7.5. Leukapheresis

        12.7.6. Erythrocytapheresis

        12.7.7. Others 

    12.8. Market Size (US$ Mn) Forecast, By Technology

        12.8.1. Centrifugation

        12.8.2. Membrane filtration

    12.9. Market Size (US$ Mn) Forecast, By End User

        12.9.1. Hospitals 

        12.9.2. Blood Collection Centers

            12.9.2.1. Public

            12.9.2.2. private

    12.10. Market Attractiveness Analysis 

        12.10.1. By Country

        12.10.2. By Product

        12.10.3. By Application

        12.10.4. By Procedure

        12.10.5. By Technology

        12.10.6. By End User

13. Asia Pacific Apheresis Market (Therapeutic Apheresis & Donor Apheresis) Analysis and Forecast

    13.1. Introduction & Definition

    13.2. Key Findings / Developments

    13.3. Key Trends

    13.4. Market Size (US$ Mn) Forecast, By Country

        13.4.1. Japan

        13.4.2. China

        13.4.3. India

        13.4.4. Australia

        13.4.5. Rest of Asia Pacific

    13.5. Market Size (US$ Mn) Forecast By Product

        13.5.1. Devices

        13.5.2. Disposables

    13.6. Market Size (US$ Mn) Forecast, By Application

        13.6.1. Renal diseases

        13.6.2. Neurology

        13.6.3. Hematology

        13.6.4. Cancer

        13.6.5. Autoimmune disease 

        13.6.6. Cardiovascular diseases 

        13.6.7. Others 

    13.7. Market Size (US$ Mn) Forecast By Procedure

        13.7.1. Plasmapheresis

        13.7.2. Photopheresis

        13.7.3. LDL-apheresis

        13.7.4. Plateletpheresis

        13.7.5. Leukapheresis

        13.7.6. Erythrocytapheresis

        13.7.7. Others 

    13.8. Market Size (US$ Mn) Forecast, By Technology

        13.8.1. Centrifugation

        13.8.2. Membrane filtration

    13.9. Market Size (US$ Mn) Forecast, By End User

        13.9.1. Hospitals 

        13.9.2. Blood Collection Centers

            13.9.2.1. Public

            13.9.2.2. private

    13.10. Market Attractiveness Analysis 

        13.10.1. By Country

        13.10.2. By Product

        13.10.3. By Application

        13.10.4. By Procedure

        13.10.5. By Technology

        13.10.6. By End User

14. Latin America Apheresis Market (Therapeutic Apheresis & Donor Apheresis) Analysis and Forecast

    14.1. Introduction & Definition

    14.2. Key Findings / Developments

    14.3. Key Trends

    14.4. Market Size (US$ Mn) Forecast, By Country

        14.4.1. Brazil

        14.4.2. Mexico

        14.4.3. Rest of Latin America 

    14.5. Market Size (US$ Mn) Forecast By Product

        14.5.1. Devices

        14.5.2. Disposables

    14.6. Market Size (US$ Mn) Forecast, By Application

        14.6.1. Renal diseases

        14.6.2. Neurology

        14.6.3. Hematology

        14.6.4. Cancer

        14.6.5. Autoimmune disease 

        14.6.6. Cardiovascular diseases 

        14.6.7. Others 

    14.7. Market Size (US$ Mn) Forecast By Procedure

        14.7.1. Plasmapheresis

        14.7.2. Photopheresis

        14.7.3. LDL-apheresis

        14.7.4. Plateletpheresis

        14.7.5. Leukapheresis

        14.7.6. Erythrocytapheresis

        14.7.7. Others 

    14.8. Market Size (US$ Mn) Forecast, By Technology

        14.8.1. Centrifugation

        14.8.2. Membrane filtration

    14.9. Market Size (US$ Mn) Forecast, By End User

        14.9.1. Hospitals 

        14.9.2. Blood Collection Centers

            14.9.2.1. Public

            14.9.2.2. private

    14.10. Market Attractiveness Analysis 

        14.10.1. By Country

        14.10.2. By Product

        14.10.3. By Application

        14.10.4. By Procedure

        14.10.5. By Technology

        14.10.6. By End User

15. Middle East & Africa Apheresis Market (Therapeutic Apheresis & Donor Apheresis) Analysis and Forecast

    15.1. Introduction & Definition

    15.2. Key Findings / Developments

    15.3. Key Trends

    15.4. Market Size (US$ Mn) Forecast, By Country

        15.4.1. Saudi Arabia

        15.4.2. South Africa

        15.4.3. Rest of MEA

    15.5. Market Size (US$ Mn) Forecast By Product

        15.5.1. Devices

        15.5.2. Disposables

    15.6. Market Size (US$ Mn) Forecast, By Application

        15.6.1. Renal diseases

        15.6.2. Neurology

        15.6.3. Hematology

        15.6.4. Cancer

        15.6.5. Autoimmune disease 

        15.6.6. Cardiovascular diseases 

        15.6.7. Others

    15.7. Market Size (US$ Mn) Forecast By Procedure

        15.7.1. Plasmapheresis

        15.7.2. Photopheresis

        15.7.3. LDL-apheresis

        15.7.4. Plateletpheresis

        15.7.5. Leukapheresis

        15.7.6. Erythrocytapheresis

        15.7.7. Others

    15.8. Market Size (US$ Mn) Forecast, By Technology

        15.8.1. Centrifugation

        15.8.2. Membrane filtration

    15.9. Market Size (US$ Mn) Forecast, By End User

        15.9.1. Hospitals 

        15.9.2. Blood Collection Centers

            15.9.2.1. Public

            15.9.2.2. private

    15.10. Market Attractiveness Analysis 

        15.10.1. By Country

        15.10.2. By Product

        15.10.3. By Application

        15.10.4. By Procedure

        15.10.5. By Technology

        15.10.6. By End User

16. Competition Landscape

    16.1. Market Player – Competition Matrix (By Tier and Size of companies)

    16.2. Company Profiles (Details – Overview, Financials, Recent Developments, Strategy)

        16.2.1. Asahi Kasei Medical Co., Ltd.

            16.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.2.1.2. Product Portfolio

            16.2.1.3. SWOT Analysis

            16.2.1.4. Financial Overview

            16.2.1.5. Strategic Overview

        16.2.2. B. Braun Melsungen AG

            16.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.2.2.2. Product Portfolio

            16.2.2.3. SWOT Analysis

            16.2.2.4. Financial Overview

            16.2.2.5. Strategic Overview

        16.2.3. Cerus Corporation 

            16.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.2.3.2. Product Portfolio

            16.2.3.3. SWOT Analysis

            16.2.3.4. Financial Overview

            16.2.3.5. Strategic Overview

        16.2.4. Fresenius Medical Care

            16.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.2.4.2. Product Portfolio

            16.2.4.3. SWOT Analysis

            16.2.4.4. Financial Overview

            16.2.4.5. Strategic Overview

        16.2.5. Haemonetics Corp.

            16.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.2.5.2. Product Portfolio

            16.2.5.3. SWOT Analysis

            16.2.5.4. Financial Overview

            16.2.5.5. Strategic Overview

        16.2.6. Hemacare Corporation

            16.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.2.6.2. Product Portfolio

            16.2.6.3. SWOT Analysis

            16.2.6.4. Financial Overview

            16.2.6.5. Strategic Overview

        16.2.7. Kawasumi Laboratories Inc.

            16.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.2.7.2. Product Portfolio

            16.2.7.3. SWOT Analysis

            16.2.7.4. Financial Overview

            16.2.7.5. Strategic Overview

        16.2.8. Medica S.p.A.

            16.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.2.8.2. Product Portfolio

            16.2.8.3. SWOT Analysis

            16.2.8.4. Financial Overview

            16.2.8.5. Strategic Overview

        16.2.9. NIKKISO CO., LTD.

            16.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.2.9.2. Product Portfolio

            16.2.9.3. SWOT Analysis

            16.2.9.4. Financial Overview

            16.2.9.5. Strategic Overview

        16.2.10. Terumo Corporation

            16.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.2.10.2. Product Portfolio

            16.2.10.3. SWOT Analysis

            16.2.10.4. Financial Overview

            16.2.10.5. Strategic Overview

        16.2.11. Therakos, Inc.

            16.2.11.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.2.11.2. Product Portfolio

            16.2.11.3. SWOT Analysis

            16.2.11.4. Financial Overview

            16.2.11.5. Strategic Overview

Fact.MR offers custom research services that help clients to get specific research solutions

We are committed towards customer satisfaction and quality service.


Our Clients

Malaysian Cocoa Board
Dunlop International Europe Ltd
Roland Berger
Superior Essex
Commscope
Deloitte

Fact.MR in Media

Apheresis Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2020 to 2025